Critics of the bill suggested that it would allow patents on pathogen genetic material, which could hamper the ability to test and treat in future pandemics.
US Senate Hearings Consider Bipartisan Proposal to Change Patent Laws; Could Have Big Impact on Dx
A draft bill provides for a major expansion of eligible material, a move the ACLU and AMP said threatens to reduce competition in genetic testing.
Industry reactions to the US Supreme Court's decision to invalidate patents on isolated gene sequences were immediate and ranged from elation to disappointment.
Originally published Feb. 17. By Turna Ray
Mar 30, 2011
Senate Close on SBIR Bill
Feb 4, 2011
Patent Reform Back on Senate's Agenda
Oct 2, 2009
Apr 24, 2009
BioRegion Newsmakers, 2009.04.24
Apr 22, 2009
Apr 6, 2009
Mar 4, 2009